Adenosine Diphosphate

Adenosine Diphosphate

SCHEMBL30691918

[15NH2]c1[15n]c[15n]c2c1[15n]c[15n]2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 7/20 0.92
▸ P2RY2 P41231 4/20 0.92
▸ P2RX1 P51575 4/20 0.92
▸ P2RX3 P56373 4/20 0.92
▸ SRC P12931 2/20 0.92
▸ SMN1; SMN2 Q16637 2/20 0.92
▸ P2RX2 Q9UBL9 2/20 0.92
▸ ALDH1A1 P00352 2/20 0.92
▸ P2RX4 Q99571 1/20 0.92
▸ RNASEL Q05823 1/20 0.86
▸ TRPM2 O94759 2/20 0.86
▸ MACROD2 A1Z1Q3 1/20 0.86
▸ SIRT6 Q8N6T7 1/20 0.86
▸ MACROD1 Q9BQ69 1/20 0.86
▸ TAS1R3 Q7RTX0 2/20 0.85
▸ TAS1R1 Q7RTX1 2/20 0.85
▸ DNPH1 O43598 1/20 0.85
▸ PRKAB2 O43741 1/20 0.85
▸ LDHA P00338 1/20 0.85
▸ ADRB2 P07550 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Diphosphate SCHEMBL29979301 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL24103 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL29358868 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL18785159 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL14613190 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL18089780 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL12789537 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL195251 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL135142 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC
Adenosine Diphosphate SCHEMBL14180716 1.00 P2RY1 (0.92) P2RY1P2RY2P2RX1P2RX3SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260036547-A1 METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM ASTRAZENECA AB (SE) 2026-02-05 — — US disclosed
EP-4562420-A1 METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM Astrazeneca AB (SE) 2025-06-04 — — EP disclosed
WO-2024023317-A1 METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM ASTRAZENECA AB (SE) 2024-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260036547-A1 METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM ATP5ME, ATP5MF, ATP5MK P2RY1 46/4885P2RY2 16/4885P2RX1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback